Roper MG, Qian W-J, Zhang BB, Kulkarni RN, Kahn R, Kennedy RT. Effect of the insulin mimetic L-783,281 on intracellular [Ca2+] and insulin secretion from pancreatic $\beta$-cells. Diabetes. 2002;51(suppl 1):S43–S49.
Publications
2002
Laustsen PG, Michael D, Crute BE, Cohen SE, Ueki K, Kulkarni RN, Keller SR, Lienhard GE, Kahn R. Lipoatrophic diabetes in Irs1-/-/Irs3-/- double knockout mice. Genes & development. 2002;16(24):3213–3222.
Mauvais-Jarvis F, Kulkarni RN, Kahn R. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clinical endocrinology. 2002;57(1):1–9.
Kulkarni RN, Okada T. Tissue-specific targeting of the insulin receptor gene. Endocrine. 2002;19(3):257–266.
Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn R. $\beta$-cell–specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter $\beta$-cell mass. Nature genetics. 2002;31(1):111.
2001
Flier SN, Kulkarni RN, Kahn R. Evidence for a circulating islet cell growth factor in insulin-resistant states. Proceedings of the National Academy of Sciences. 2001;98(13):7475–7480.
Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn R, De Vargas LM, Berggren P-O. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic $\beta$ cells. Molecular cell. 2001;7(3):559–570.
2000
Kulkarni R, Wang Z, Wang R, Smith D, Ghatei M, . Glibenclamide but not other sulphonylureas stimulates release of neuropeptide Y from perifused rat islets and hamster insulinoma cells. Journal of endocrinology. 2000;165(2):509–518.
Mauvais-Jarvis F, Virkamaki A, Michael D, Winnay JN, Zisman A, Kulkarni RN, Kahn R. A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes.. Diabetes. 2000;49(12):2126–2134.